Biomarkers in Neuroimaging


Neuroimaging has helped to elucidate that substance-use disorders are associated with changes in brain structure, function, and neurochemistry. Neuroimaging studies have improved our understanding of the neural correlates of addiction and how these relate to addictive behavior. Nevertheless, the potential impact of neuroimaging on treatment development for addictions has yet to be fully realized. Despite substantial advances, treatments are often not fully effective, and addiction continues to be a major public health burden . Neuroimaging has contributed to our appreciation of the complexity of addiction, highlighting the need for measurable indices, or biomarkers, of addiction to improve treatment outcomes. A “biomarker” typically refers to a measurable indicator of normal or abnormal biological processes or response to treatment . In substance-abuse research, biomarkers are needed to clarify how or why a treatment has an effect, on whom and under what circumstances.



Recent advances in neuroimaging are affording greater opportunities to identify brain biomarkers that might be used to improve outcomes of treatment for substance-use disorders. Neuroimaging is a critical tool in biomarker development because it relates neural circuits to both molecular mechanisms and behavior or clinical variation. In particular, neuroimaging studies are central to an emerging research effort to identify cross-diagnostic processes in substance-use and related disorders based on both behavior and neural circuits . In this work, alterations in brain activation patterns related to dimensions of functioning in individuals with addictions may be considered to represent abnormal processing associated with addictive behavior. Such research holds significant potential for identifying targets for treatment, detecting subgroups for treatment selection, and/or predicting treatment response . As disorder heterogeneity and individual variation pose significant challenges for delivering effective treatment, considering addictions in terms of dimensions of functioning may help to elucidate factors relevant to treatment response and lead to more specific, more effective treatments . This paper reviews neuroimaging research seeking to identify potential biomarkers of treatment response from several dimensions of functioning relevant to addiction:, impulsivity, and cognitive control.



 


  • Molecular
  • Histologic
  • Radiographic
  • Physiologic

Related Conference of Biomarkers in Neuroimaging

January 24-25, 2022

World Neuroscience Summit

Prague, Czech Republic
January 24-25, 2022

2nd Global Summit on Neurology and Neuroscience

Prague, Czech Republic
January 27-27, 2022

2nd Webinar on Neurology Research

Paris, France
February 09-10, 2022

31st World Congress on Neurology and Therapeutics

London, UK
March 09-10, 2022

International Conference on Alzheimer and Dementia

Paris, France
March 23-24, 2022

35th European Neurology Congress 2022

Amsterdam, Netherlands
April 28-29, 2022

3rd International Conference on Neurologists

Amsterdam, Netherlands
May 23-24, 2022

10th World Congress on Depression and Anxiety

Singapore City, Singapore
May 23-24, 2022

36th European Neurology Congress

Vienna, Austria
May 25-26, 2022

25th International conference on Neurology and Psychiatry

Zurich, Switzerland
May 25-26, 2022

EURO NEUROPHARMACOLOGY 2022

Valencia, Spain
June 03-04, 2022

35th World Neuroscience and Neurology Conferences

Dublin, Ireland
June 03-04, 2022

35th World Congress for Neurorehabilitation

Dublin, Ireland
June 13-14, 2022

12th World Congress on Mental Health and Neuro Infection

Zurich, Switzerland
June 19-20, 2022

14th Asia Pacific Pediatrics Congress

Singapore City, Singapore
June 27-28, 2022

2nd Global Summit on Brain Disorders and Therapeutics

Prague, Czech Republic
July 13-14, 2022

13th World Congress on Alzheimers Disease & Dementia

Bangkok, Thailand
July 18-19, 2022

8th International Conference on Epilepsy & Treatment

Amsterdam, Netherlands
July 18-19, 2022

34th World Conference on Neurology

Vienna, Austria
July 18-19, 2022

17th Annual Congress on Neuroscience

Tokyo, Japan
July 25-26, 2022

Neurology Surgery

Toronto, Canada
August 11-12, 2022

5th World Congress on Epilepsy and Brain Disorders

Berlin, Germany
August 11-12, 2022

4th World Depression Congress

Berlin, Germany
August 22-23, 2022

5th International Conference on Neurology and Psychology

Amsterdam, Netherlands
August 24-25, 2022

4th World Congress on Nursing Education & Management

Toronto, Aland Islands
September 05-06, 2022

3rd International Congress on Neurology 2022

Amsterdam, Netherlands
September 26-27, 2022

28th World Congress on Neurology and Neurodisorders

Rome, Italy
September 27-28, 2022

World Congress on Neurosurgery and Neuroscience

Berlin, Germany
October 10-11, 2022

28th Global Experts Meeting on Neuropharmacology

Vienna, Austria
October 24-25, 2022

5th World Neuron Congress

Paris, France
October 24-25, 2022

31st Euro Congress on Neurologists and Psychiatrists

Paris, France
October 26-27, 2022

International Conference on stress & mental health

Amsterdam, Netherlands
October 31-01, 2022

6th Global Congress on Spine and Spinal Disorders

Rome, Italy
November 02-03, 2022

9th International Conference on ENT Surgery

Rome, Italy
November 14-15, 2022

3rd World Congress on Sleep Disorders and Therapeutics

Amsterdam, Netherlands
November 21-22, 2022

2nd World Neurologist Congress

Rome, Italy
November 28-29, 2022

Nephrology Congress 2022

Singapore City, Singapore
December 05-06, 2022

17th Annual Conference on Dementia and Alzheimers Disease

Quattromiglia, Italy
December 08-09, 2022

7th World Congress on Spine and Spinal Disorders

Tokyo, Japan
December 15-16, 2022

29th Cognitive Neuroscience Congress

Prague, Aland Islands

Biomarkers in Neuroimaging Conference Speakers

Recommended Sessions

Related Journals

Are you interested in